CJ-12420 100 mg QD

DRUG2 trials

Sponsors

HK inno.N Corporation

Conditions

Erosive EsophagitisGastric Ulcer

Phase 3

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

CompletedNCT02456935

HK inno.N CorporationErosive Esophagitis

Start: 2015-05-31End: 2016-09-30Updated: 2016-12-15

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer

CompletedNCT02761512

HK inno.N CorporationGastric Ulcer

Start: 2016-05-31End: 2018-12-28Updated: 2019-08-22